Free Trial
NASDAQ:DYAI

Dyadic International (DYAI) Stock Price, News & Analysis

Dyadic International logo
$0.33 -0.02 (-6.60%)
Closing price 11/13/2026 04:00 PM Eastern
Extended Trading
$0.36 +0.03 (+9.17%)
As of 11/13/2026 05:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Dyadic International Stock (NASDAQ:DYAI)

Advanced

Key Stats

Today's Range
$0.32
▼
$0.35
50-Day Range
$0.33
▼
$0.52
52-Week Range
$0.32
▼
$1.60
Volume
189,367 shs
Average Volume
83,523 shs
Market Capitalization
$13.10 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

Dyadic International is a biotechnology company developing microbial expression systems to produce proteins for human and animal health applications. Its platforms are designed to help partners develop and manufacture biologics, including vaccines, therapeutics and diagnostic products.

The company’s technologies include its C1 fungal expression system, based on a non-pathogenic microorganism, and its Dapibus yeast platform. Dyadic licenses these systems and related expertise to collaborators and also pursues development of selected products for health applications.

Dyadic has roots in industrial biotechnology and has shifted its focus toward biopharmaceutical development. Based in Jupiter, Florida, the company works with partners serving markets internationally. Founder Mark Emalfarb has led the company as its chief executive.

AI Generated. May Contain Errors.

Dyadic International Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
20th Percentile Overall Score

DYAI MarketRank™: 
1.00224333597 of 5 stars

Dyadic International scored higher than 20% of companies evaluated by MarketBeat, and ranked 821st out of 893 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Dyadic International has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Dyadic International has only been the subject of 1 research reports in the past 90 days.

  • Read more about Dyadic International's stock forecast and price target.
  • Earnings Growth

    Earnings for Dyadic International are expected to grow in the coming year, from ($0.15) to ($0.08) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Dyadic International is -1.56, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Dyadic International is -1.56, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Dyadic International has a P/B Ratio of 10.90. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    0.26% of the float of Dyadic International has been sold short.
  • Short Interest Ratio / Days to Cover

    Dyadic International has a short interest ratio ("days to cover") of 0.99, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Dyadic International has recently decreased by 57.26%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Dyadic International does not currently pay a dividend.

  • Dividend Growth

    Dyadic International does not have a long track record of dividend growth.

  • News Sentiment

    Dyadic International has a news sentiment score of 0.36. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.60 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 13 news articles for Dyadic International this week, compared to 2 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Dyadic International insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    20.90% of the stock of Dyadic International is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    27.95% of the stock of Dyadic International is held by institutions.

  • Read more about Dyadic International's insider trading history.
Receive DYAI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Dyadic International and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

DYAI Stock News Headlines

Dyadic (DYAI) Q3 2026 Earnings Call Transcript
Unbelievable…Congress is About to Do What?
Jim Rickards, former advisor to the CIA, the Pentagon and the White House, says a key turning point in Washington is set to take place by November 30th. He believes it could create one of the most chaotic environments in America's history. He predicts those who understand what's happening could do very well over the next 12-18 months, while others may face steep losses. Rickards outlines the five steps he recommends.tc pixel
Dyadic: 3 Key Takeaways for Long-Term Investors
See More Headlines

DYAI Stock Analysis - Frequently Asked Questions

Dyadic International's stock was trading at $0.94 at the beginning of 2026. Since then, DYAI stock has decreased by 65.2% and is now trading at $0.3270.

Dyadic International Inc. (NASDAQ:DYAI) issued its quarterly earnings results on Thursday, November, 12th. The biotechnology company reported ($0.05) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.05) by $0.01. The biotechnology company had revenue of $449.10 thousand for the quarter, compared to analysts' expectations of $1.43 million. Dyadic International had a negative trailing twelve-month return on equity of 2,920.31% and a negative net margin of 226.85%.
Read the conference call transcript
.

Shares of DYAI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Dyadic International investors own include Pfizer (PFE), Vaxart (VXRT), Alibaba Group (BABA), GE Aerospace (GE), ADMA Biologics (ADMA), Micron Technology (MU) and NVIDIA (NVDA).

Company Calendar

Last Earnings
11/12/2026
Today
11/15/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:DYAI
CIK
1213809
Employees
5
Year Founded
1979

Profitability

EPS (Trailing Twelve Months)
($0.23)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$7.36 million
Net Margins
-226.85%
Pretax Margin
-201.43%
Return on Equity
-2,920.31%
Return on Assets
-93.22%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.65
Quick Ratio
1.65

Sales & Book Value

Annual Sales
$3.09 million
Price / Sales
4.24
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.03 per share
Price / Book
10.90

Miscellaneous

Outstanding Shares
40,060,000
Free Float
31,691,000
Market Cap
$13.10 million
Optionable
Optionable
Beta
1.10

Social Links

The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

This page (NASDAQ:DYAI) was last updated on 11/13/2026 by MarketBeat.com Staff.
From Our Partners